Poisonous Pill, Inc. (Poisonous) is a publicly traded corporation…

Question Answered step-by-step Poisonous Pill, Inc. (Poisonous) is a publicly traded corporation… Poisonous Pill, Inc. (Poisonous) is a publicly traded corporation of which Wren Waarowned 1 million Class A common shares of the company and 3 million of the Class B common.The Class A shares had 10 votes per share while the Class A shares had 1 vote per share. Thus,Waar while owning only 37% of the shares in the company, held 78% of its voting power andwas able to elect the entire board of directors.In June, 2021, members of the management of Pills a Poppin, Inc. (Poppin), approachedWaar about buying part of her stake in Poisonous. Waar eventually sold one third of her Class Ashares to Poppin @ $15.00 per share. Waar’s remaining shares still controlled Poisonous.Sometime thereafter, Poppin approached Waar about the possibility of buying out the publicshareholders other than Waar (the unaffiliated shareholders). Negotiations continued and aproposed merger agreement was reached where Poppin would buy the shares of the unaffiliatedshareholders @ $15 per share in cash. Waar would commit to vote for the merger, would remainas chair and CEO of the merged company, and would appoint a majority of its board. Waarwould also agree that if the merger did not close, she would not vote for a competing merger fora period of 1 year after the termination of the Poppin merger agreement.Poisonous appointed a special committee of outside directors to study the proposed dealand to make recommendations to the board about whether to accept. The committee also had thepower to negotiate with Poppin concerning changes it desired before making itsrecommendation. As a result of those negotiations the proposed agreement was modified toprovide the unaffiliated shareholders $15.25 per share, that there would be a majority of theminority provision for shareholder approval of the merger, and the period during which Waarwas prohibited from voting for a competing merger was increased to 2 years.The committee then recommended that Poisonous’ board approve the merger. At theboard meeting, Waar urged acceptance and the board complied. When Poisonous sent out itsproxy statement to shareholders for the vote on the merger agreement, it listed the details of thetransaction, including Waar’s continued role and controlling shareholder interest but did notdisclose the 2 year prohibition on Waar’s voting for a competing merger should the Poppinmerger terminate.Some of the unaffiliated shareholders of Poisonous bring suit to enjoin the merger. Theyclaim breach of duties by Waar and the other directors, that the merger was subject to animpermissible lockup, and Securities Exchange Act violations. Waar and Poisonous respondwith a motion for summary judgment in which they claim that the Poisonous board is entitled tothe benefit of the business judgment rule, that there were no breaches of duty or federal securitieslaws, and that Unocal and Revlon and their progeny did not applyI need the law clerk’s recommendations for solving issues raised by Waar and Poisonous’ Motion. Business Management Business Law LAW MISC Share QuestionEmailCopy link Comments (0)